Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001951 |
---|---|
Receipt number | R000002334 |
Scientific Title | Phase II study of biweekly cetuximab plus irinotecan for unresectable colorectal cancer |
Date of disclosure of the study information | 2009/05/11 |
Last modified on | 2011/11/09 13:33:00 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/05/09 12:28:11 | ||
2 | Update | 2011/11/09 13:32:19 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2011/11/09 13:33:00 | Recruitment status Publication of results |